Health-related quality of life measurement in women with common benign gynecologic conditions: A systematic review

American Journal of Obstetrics and Gynecology

Volumn 187, Issue 2, 2002, Pages 501-511

  Jones, Georgina L ^a,b   Kennedy, Stephen H ^a   Jenkinson, Crispin ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

chronic pelvic pain; Endometriosis; health related quality of life; menorrhagia; polycystic ovary syndrome

Indexed keywords

ENDOMETRIOSIS; FEMALE; GYNECOLOGIC DISEASE; HEALTH STATUS; HUMAN; INTERVIEW; MENORRHAGIA; OVARY POLYCYSTIC DISEASE; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SYMPTOMATOLOGY;

EID: 0036679428     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2002.124940     Document Type: Article

References (86)

1. A health-related quality of life instrument for symptomatic patients with endometriosis: A validation study
2. Mass screening: Theory and ethics
3. Quality of life in gynecologic cancer survivors
4. Quality of life as an outcome measure in gynecologic malignancies
5. Quality of life in patients with gynecologic cancer
6. Quality of life in gynaecological oncology
7. Quality of life in patients with ovarian cancer: Current state of research
8. Quality, of life issues in the management of ovarian cancer
9. Quality of life in progressive ovarian cancer
10. Quality of life in women with ovarian cancer
11. Quality counts: The value of women’s perceived quality of life after cervical cancer
12. Stress and quality of life following cervical cancer
13. The emotional aspects of endometriosis: What the patient expects from her doctor
14. The emotional aspects of endometriosis: A physicians perspective
15. Psychosocial aspects of endometriosis: A review
16. Relationship between endometriosis and affective disorder
17. Bipolar mood disorder and endometriosis: Preliminary findings
18. A psychological profile of endometriosis patients in comparison to patients with pelvic pain of other origins
19. Psychosocial factors and chronic pelvic pain: A comparison of women with endometriosis and with unexplained pain
20. Endometriosis, pelvic pain, and psychological functioning
21. Quality of life of hirsute women
22. The prevalence of dysmenorrhea, dyspareunia, pelvic pain and irritable bowel syndrome in primary practices
23. Quality of life instruments in oncology
24. Patient-assessed outcome measures
25. Quality of life measurement in breast cancer
26. Management of pelvic pain recurrence: A quality of life issue in endometriosis
27. Pain recurrence: A quality of life issue in endometriosis
28. Health-related quality of life after hysterectomy
29. Cost and quality-of-life issues associated with different surgical therapies for the treatment of abnormal uterine bleeding
30. Quality of life during menstruation in patients with inherited bleeding disorders
31. Psychosocial and economic impact of chronic pelvic pain
32. Impact of nafarelin and leuprolide for endometriosis on quality of life and subjective clinical measures
33. Long-term follow up on the treatment of endometriosis with the GnRH-agonist buserelin acetate. Long-term follow up data (up to 98 months) of 42 patients with endometriosis who were treated with GnRH-agonist buserelin acetate (Suprecur), were evaluated in respect of recurrence of pain symptoms and pregnancy outcome
34. Thermal balloon and rollerball ablation to treat menorrhagia: A multicenter comparison
35. Medium-term follow-up of women with menorrhagia treated by rollerball endometrial ablation
36. Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia
37. A medical audit and patient survey of hysterectomies performed for menstrual disorders
38. A pilot study to assess the learning curve in transcervical endometrial resection: Possible implications for postgraduate accreditation
39. The prevalence of continuing chronic pelvic pain following a negative laparoscopy
40. Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia
41. Hysterectomy: Analysis of the effectiveness of psychological preparation for surgery on post operation quality of life
42. Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy
43. Elective hysterectomy: Benefits, risks and costs
44. A cost utility analysis of sono-hysteroscopy compared with hysteroscopic evaluation for dysfunctional uterine bleeding
45. Randomised trial comparing hysterotomy with endometrial ablation for dysfunctional uterine bleeding: Psychiatric and psychosocial aspects
46. Endometrial resection versus vaginal hysterectomy for menorrhagia: Long term clinical and quality-of-life outcomes
47. Effectiveness of hysterectomy
48. The Maine Women’s Health Study: I. Outcomes of hysterectomy
49. The Maine Women’s Health Study: II. Outcomes of non surgical management of leiomyomas, abnormal bleeding and chronic pelvic pain
50. Measuring health-related quality of life outcomes in women with endometriosis: Results of the gynaecology audit project in Scotland
51. Nafarelin in the management of endometriosis: Quality of life assessment
52. Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: A double-blind, randomized, placebo-controlled trial
53. The effect of endometriosis and its radical laparoscopic excision on quality of life indicators
54. Perceptions of women on the impact of menorrhagia on their health using multi-attribute utility assessment
55. Development and validation of the menorrhagia outcomes questionnaire
56. Patient centered assessment of quality of life for patients with four common conditions
57. Measuring change over time: A comparison of results from a global single item of health stares and the multi-dimensional SF-36 health status survey questionnaire in patients presenting with menorrhagia
58. The SF36 health survey questionnaire: An outcome measure suitable for routine use within the NHS
59. An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia
60. Intermittent leuprolide acetate for the nonsurgical management of women with leiomyomata uteri
61. Quality of life and patient satisfaction following treatment for menorrhagia
62. Randomised trial comparing hysterectomy and transcervical endometrial resection: Effect on health related quality of life and costs two years after surgery
63. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding
64. Comparison of microwave endometrial ablation and transcervical resection of the endometrium for treatment of heavy menstrual loss: A randomised trial
65. A randomised comparison of medical and hysteroscopic management in women consulting a gynaecologist for treatment of heavy menstrual loss
66. Two-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: Clinical and quality of life outcomes
67. The impact of using a partially randomised patient preference design when evaluating alternative managements for heavy menstrual bleeding
68. Guidelines in gynaecology: Evaluation in menorrhagia and in urinary incontinence
69. Uterine fibroid embolization: Measurement of health-related quality of life before and after therapy
70. Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS)
71. Chronic pelvic pain: Prevalence, health related quality of life, and economic correlates
72. Quality of life among women undergoing hysterectomies
73. Indications for and outcome of total abdominal hysterectomy for benign disease: A prospective cohort study
74. Quality of life, health care utilization, and costs among women undergoing hysterectomy in a managed-care setting
75. The "ectomies"
76. Definition of life quality from a patient versus health care professional perspective
77. Quality of life in cancer patients: Who measures what?
78. Who should measure quality of life, the doctor or the patient?
79. Measurement of health status in the 1990s
80. A comparison of the sensitivity to change of several health status instruments in rheumatoid arthritis
81. Disease-specific versus generic measurement of health-related quality of life in insulin-dependent diabetic patients